Geron Corp (GERN)
3.58
+0.08
(+2.29%)
USD |
NASDAQ |
Apr 24, 16:00
3.55
-0.03
(-0.84%)
After-Hours: 20:00
Geron Accounts Payable (Quarterly): 6.161M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.161M |
September 30, 2023 | 13.68M |
June 30, 2023 | 7.673M |
March 31, 2023 | 3.383M |
December 31, 2022 | 10.19M |
September 30, 2022 | 8.183M |
June 30, 2022 | 4.521M |
March 31, 2022 | 6.245M |
December 31, 2021 | 6.687M |
September 30, 2021 | 4.714M |
June 30, 2021 | 3.758M |
March 31, 2021 | 4.459M |
December 31, 2020 | 6.919M |
September 30, 2020 | 3.739M |
June 30, 2020 | 3.797M |
March 31, 2020 | 3.376M |
December 31, 2019 | 1.181M |
September 30, 2019 | 2.031M |
June 30, 2019 | 1.21M |
March 31, 2019 | 0.913M |
December 31, 2018 | 0.982M |
September 30, 2018 | 0.19M |
June 30, 2018 | 0.458M |
March 31, 2018 | 0.502M |
December 31, 2017 | 0.503M |
Date | Value |
---|---|
September 30, 2017 | 0.261M |
June 30, 2017 | 0.205M |
March 31, 2017 | 0.308M |
December 31, 2016 | 0.225M |
September 30, 2016 | 0.271M |
June 30, 2016 | 0.235M |
March 31, 2016 | 0.396M |
December 31, 2015 | 0.16M |
September 30, 2015 | 0.574M |
June 30, 2015 | 0.957M |
March 31, 2015 | 1.18M |
December 31, 2014 | 1.033M |
September 30, 2014 | 2.365M |
June 30, 2014 | 1.223M |
March 31, 2014 | 1.52M |
December 31, 2013 | 1.397M |
September 30, 2013 | 1.547M |
June 30, 2013 | 1.176M |
March 31, 2013 | 1.669M |
December 31, 2012 | 3.429M |
September 30, 2012 | 3.014M |
June 30, 2012 | 3.429M |
March 31, 2012 | 2.666M |
December 31, 2011 | 2.98M |
September 30, 2011 | 4.006M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.181M
Minimum
Dec 2019
13.68M
Maximum
Sep 2023
5.364M
Average
4.521M
Median
Jun 2022
Accounts Payable (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 28.04M |
SELLAS Life Sciences Group Inc | 5.639M |
Johnson & Johnson | 9.632B |
Immuneering Corp | 2.112M |
Moderna Inc | 520.00M |